UC employee discounts offered for DAAPcamps
University faculty, staff and their families can take advantage of a 15 percent discount on immersive, artistic summer camps for students
Offered by the University of Cincinnati’s College of Design, Architecture, Art, and Planning, DAAPcamps are week-long immersions for high school and middle school students to explore their creative passion areas and expand their skills in specific creative disciplines. Set on the UC’s architecturally renowned campus and supervised by the faculty and staff at the globally recognized DAAP, each day at camp includes time spent on studio projects, field trips and social activities for the perfect mix of practice and inspiration.
Registration is now open for more than a dozen camp offerings and will close May 15, though many spots will fill up before then. Families of UC employees receive a 15 percent discount on camp tuition.
For more information, visit the DAAPcamps website, email daapcamps@uc.edu or call 513-556-2958.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.